BBOTVSSNYR• 28 Days (Normalized)
BBOT vs SNYR (BridgeBio Oncology Therapeutics Inc. vs Synergy CHC Corp.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-56.09%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
SNYR Performance $0.01
+%
Synergy CHC Corp.
Normalized Baseline0.00%
Alpha Spread Margin SNYR LEADS
-56.09 pts
SNYR outperforming by 56.09 percentage points
BBOTSNYR
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT SNYR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | BBOT Price | BBOT Gain (%) | SNYR Price | SNYR Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -56.09% | $- | - | |
| Sep 30, 2026 | $4.10 | -53.72% | $- | - | |
| Sep 29, 2026 | $3.92 | -55.76% | $- | - | |
| Sep 28, 2026 | $3.81 | -57.00% | $0.01 | -82.77% | +25.77% |
| Sep 25, 2026 | $3.95 | -55.42% | $0.01 | -83.61% | +28.19% |
| Sep 24, 2026 | $3.99 | -54.97% | $- | - | |
| Sep 23, 2026 | $4.16 | -53.05% | $- | - | |
| Sep 22, 2026 | $4.66 | -47.40% | $0.03 | -66.39% | +18.99% |
| Sep 21, 2026 | $4.66 | -47.40% | $0.04 | -50.60% | +3.20% |
| Sep 18, 2026 | $4.77 | -46.16% | $0.05 | -34.94% | -11.22% |
| Sep 17, 2026 | $4.89 | -44.81% | $0.09 | +9.04% | -53.85% |
| Sep 16, 2026 | $4.76 | -46.28% | $0.27 | +230.12% | -276.40% |
| Sep 15, 2026 | $4.88 | -44.92% | $0.08 | -1.20% | -43.72% |
| Sep 14, 2026 | $5.05 | -43.00% | $0.09 | +9.64% | -52.64% |
| Sep 11, 2026 | $4.95 | -44.13% | $0.10 | +21.69% | -65.82% |
Page 1 of 2